- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07268118
Pain Control for Cervical Ripening Balloon
March 3, 2026 updated by: Sarah Little, Beth Israel Deaconess Medical Center
Randomized Control Trial for Pain Control With Topical Lidocaine for Cervical Ripening Balloon Placement
No standard of care exists for pain management during cervical ripening balloon placement.
The purpose of this study is to evaluate if vaginal topical lidocaine reduces pain related to cervical ripening balloon placement during induction of labor.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
110
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sarah Little, MD
- Phone Number: 6176677000
- Email: slittl10@bidmc.harvard.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥18 years
- Gestational age ≥37 weeks
- Viable pregnancy
- Intact membranes
- English speaking
- Interested in cervical ripening balloon placement
- Able to provide consent
Exclusion Criteria:
- Allergy or sensitivity to lidocaine
- Patients that already have neuraxial anesthesia (i.e. spinal, epidural, combined spinal/epidural)
- Known uterine or cervical anomalies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard of care
|
|
|
Experimental: Topical lidocaine
|
Application of topical vaginal lidocaine prior to cervical balloon ripening
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-reported pain during cervical ripening balloon placement.
Time Frame: Within 24 hours of cervical balloon ripening
|
Patient-reported pain score during cervical ripening balloon placement on a visual analog scale from 0 (no pain) to 10 (most pain).
|
Within 24 hours of cervical balloon ripening
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Study Registration Dates
First Submitted
November 24, 2025
First Submitted That Met QC Criteria
December 3, 2025
First Posted (Actual)
December 5, 2025
Study Record Updates
Last Update Posted (Actual)
March 5, 2026
Last Update Submitted That Met QC Criteria
March 3, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2025P000734
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Induction
-
Aalto UniversityUniversity of Minnesota; University of Mississippi Medical CenterNot yet recruitingCervical Ripening | Induction of Birth | Balloon Catheter for Labor Induction | Cervical Ripening and Induction of Labor
-
Aalto UniversityHelsinki University Central Hospital; Tampere University Hospital; Jyväskylä...Not yet recruitingInduction of Labor | Cervical Ripening | Cervical Ripening and Induction of LaborFinland
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Lee WanEnrolling by invitation
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
Hadassah Medical OrganizationUnknown
-
Cairo UniversityRecruiting
-
Northwestern UniversityCompletedLabor InductionUnited States
-
Sorlandet Hospital HFCompleted
-
Mednax Center for Research, Education, Quality...Completed
Clinical Trials on topical vaginal application lidocaine gel
-
Cairo UniversityNot yet recruitingChild | Gag ReflexEgypt
-
CONRADEmory University; Centers for Disease Control and PreventionCompleted
-
Università degli Studi dell'InsubriaUnknown
-
CONRADNational Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedHIV PreventionUnited States
-
Novan, Inc.CompletedAcne VulgarisUnited States
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
-
Rhodes Pharmaceuticals, L.P.ORA, Inc.Completed
-
Maruho Co., Ltd.Leiden University Medical CenterCompletedCondylomata Acuminata (External)Netherlands
-
Novan, Inc.CompletedAcne VulgarisUnited States
-
Maruho Co., Ltd.CompletedUsual Type Vulval Intraepithelial Neoplasia (uVIN)Netherlands